|
Volumn 138, Issue 1, 2010, Pages 386-389
|
Peginterferon Alfa-2B Versus Peginterferon Alfa-2A With Ribavirin for the Treatment of Chronic Hepatitis C: The Pursuit of an Ideal
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
VIRUS RNA;
ANTIVIRAL THERAPY;
ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG DOSE COMPARISON;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEVER;
FLU LIKE SYNDROME;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LOW DRUG DOSE;
MYALGIA;
NEUTROPHIL COUNT;
PRIORITY JOURNAL;
RELAPSE;
SIDE EFFECT;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
|
EID: 72249089744
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/j.gastro.2009.11.025 Document Type: Note |
Times cited : (9)
|
References (0)
|